QC laboratories and practices.

A comprehensive review of the full requirements can be undertaken on the CDSCO website. This will equip stakeholders with the necessary knowledge to allocate CAPA responsibilities effectively.

Step 2: Establish a Clear Technical Quality Agreement (TQA)

The Technical Quality Agreement (TQA) serves as a formal document that delineates the quality-related responsibilities of both Principal Manufacturers and Contract Manufacturing Organizations (CMOs). Creating a TQA is crucial for defining how CAPA responsibilities will be handled. The following elements should be included:

• Roles and Responsibilities: Clearly outline the roles of both parties in the event of a deviation or non-conformance.
• Notification Procedures: Define how and when partners must communicate any quality issues or deviations.
• CAPA Management: Establish a joint CAPA process, including timelines for actions, updates, and communications.

The TQA should reflect both regulatory compliance and the specific needs of the manufacturing partnership. Add applicable clauses regarding data ownership and third-party testing controls, explicitly stating how data will be managed and shared.

Step 3: Conduct Risk Assessments for CAPA Processes

One of the foundational components of a GMP framework under Schedule M is understanding the risks associated with the manufacturing processes you are outsourcing. Conducting risk assessments involves:

• Identifying Risks: Assess potential risks related to the outsourced activities, considering factors such as product complexity and past performance records.
• Risk Evaluation: Establish criteria for determining the severity and likelihood of identified risks, including quality risk sharing with CMOs.
• Implementing Controls: For all identified risks, develop controls that mitigate their impact.

Following the guidelines of ICH for Quality Risk Management will enhance the rigor of this assessment process. Documentation of these assessments should be maintained, enabling effective audits and reviews.

Step 4: Implement Robust Training Programs for Personnel

Training is a vital aspect of ensuring that all personnel involved understand their responsibilities concerning CAPA processes. Develop and implement a comprehensive training program that encompasses:

• Regulatory Knowledge: Regular updates on Schedule M and associated GMP regulations to keep teams informed.
• Specific Procedures: Training on document control, CAPA management, and reporting processes tailored to each partner’s operating environment.
• Continuous Improvement: Promote a culture that encourages proactive reporting and resolution of quality deviations.

Training documentation, including attendance records and training materials, must be maintained as evidence of compliance during inspections.

Step 5: Develop CAPA Documentation and Templates

Proper documentation is essential for transparency and compliance. Create standardized templates for CAPA documentation that include:

• CAPA Request Form: A format for partners to submit requests when deviations occur.
• Investigation Reports: Templates for documenting investigations of deviations, including root cause analysis.
• Action Plans: Formats to outline corrective actions that will be taken, including assigned responsibilities and timelines.

Documentation must align with requirements from both the CDSCO and other relevant regulatory bodies such as the EMA. It serves as a crucial reference point during regulatory inspections. Ensure that all CAPA records are easily accessible and stored in a centralized system.

Step 6: Ensure Ongoing CAPA Process Oversight and Review

Once the CAPA processes are in place, continuous oversight is vital for ensuring efficacy and compliance. Implement the following practices:

• Monthly Review Meetings: Schedule regular meetings with CMO/MO partners to review any active CAPAs.
• Metrics Tracking: Establish key performance indicators (KPIs) for monitoring the effectiveness of corrective and preventive actions.
• Management Review: An annual management review should assess the adequacy and effectiveness of the overall CAPA system.

These activities not only maintain compliance with Schedule M but also foster continuous improvement across all manufacturing processes. Documentation of meeting minutes and decisions is necessary to provide evidence of oversight activities.

Step 7: Prepare for Regulatory Audits and Inspections

Finally, preparation for regulatory audits from bodies such as CDSCO or global entities like US FDA is essential. To ensure readiness, conduct internal audits to evaluate compliance with Schedule M requirements. Key activities include:

• Mock Audits: Simulate regulatory inspections to assess the readiness of both Principal Manufacturers and partners.
• Corrective Actions: Address any findings from internal audits promptly and document the measures taken.
• Engagement with Auditors: Develop a rapport with auditors and be prepared to provide requested documents, such as TQAs, CAPA records, and training logs.

Such preparations enhance stakeholder confidence and ensure the integrity of the production and analytical processes are upheld under Schedule M.